Status:
RECRUITING
TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery
Lead Sponsor:
Medical University of Warsaw
Collaborating Sponsors:
Medical Research Agency, Poland
Conditions:
Liver Metastases
Liver Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Liver resection is the treatment of choice in patients with malignant liver lesions. Unfortunately, the surgery is not always an option, as in same patients the future remnant liver (FRL) is too small...
Detailed Description
Liver resection is the treatment of choice in patients with malignant liver lesions. Unfortunately, the surgery is not always an option, as in same patients the future remnant liver (FRL) is too small...
Eligibility Criteria
Inclusion
- age \>= 18 years
- patients qualified for liver resection
- future remnant liver \<30% of standard liver volume
- written informed consent
Exclusion
- liver cirrhosis
- pregnancy
- poor general health status or comorbidities excluding general anesthesia or hepatic resection
- contraindications to iodine contrast agents
Key Trial Info
Start Date :
August 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2029
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT06050200
Start Date
August 28 2024
End Date
May 1 2029
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Department of Clinical Radiology
Warsaw, Masovian Voivodeship, Poland, 02-097